OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Major depressive disorder: Validated treatments and future challenges
Rabie Karrouri, Zakaria Hammani, Roukaya Benjelloun, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 31, pp. 9350-9367
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Biotics vs food systems: Challenges and perspectives
Wilson Josè Fernandes Lemos, Andre Fiorante Guerra, Stefano Campanaro, et al.
Food Research International (2025), pp. 115806-115806
Open Access | Times Cited: 4

Omega-3 Polyunsaturated Fatty Acids in Depression
Anna Serefko, Monika Elżbieta Jach, Marlena Pietraszuk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8675-8675
Open Access | Times Cited: 17

Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Adam Gędek, Zofia Szular, Anna Antosik-Wójcińska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3497-3497
Open Access | Times Cited: 21

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
Win Lee Edwin Wong, Chiara Fabbri, Benjamin Laplace, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1277-1277
Open Access | Times Cited: 18

Overview of treatment-resistant depression
Cheng‐Ta Li
Progress in brain research (2023), pp. 1-23
Closed Access | Times Cited: 15

Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
Philip Borsellino, Reese I. Krider, Deanna Chea, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 742-742
Open Access | Times Cited: 14

Effectiveness of online cognitive behavioural therapy on quality of life in adults with depression: A systematic review
Melissa Fadipe, Seema Aggarwal, Constance Johnson, et al.
Journal of Psychiatric and Mental Health Nursing (2023) Vol. 30, Iss. 5, pp. 885-898
Closed Access | Times Cited: 11

YY1 (Yin‐Yang 1), a transcription factor regulating systemic inflammation, is involved in cognitive impairment of depression
Jing Lü, Kangyu Jin, Jianping Jiao, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 3, pp. 149-159
Closed Access | Times Cited: 17

Current and future directions of drug delivery for the treatment of mental illnesses
Parker Brewster, Saif Mohammad Ishraq Bari, Glenn M. Walker, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114824-114824
Open Access | Times Cited: 10

Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model
Max van Baalen, Lars van der Velden, Toon van der Gronde, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access

Effect of Withania somnifera on Expression of Selected Genes in Hippocampus of Male Wistar Rats Subjected to Chronic Unpredictable Mild Stress
J. P. Mehta, Urmila Anil Kagal, Prakash R. Biradar
International Journal of Applied and Basic Medical Research (2025) Vol. 15, Iss. 1, pp. 25-31
Closed Access

Seltorexant for major depressive disorder
Kyle Valentino, Kayla M. Teopiz, Sabrina Wong, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access

Efficacy of probiotic adjuvant therapy in women with major depressive disorder: insights from a case series study
Jony Arrais Pinto, Rafaela Aires, Thiago Antonio de Sousa Cutrim, et al.
Pharmacological Reports (2025)
Closed Access

Effects of prenatal cannabinoid use on the monoamine system in the fetoplacental unit: a systematic review of animal and human studies
Ramón Portillo, Tetiana Synova, František Štaud
Drug and Alcohol Dependence (2025), pp. 112579-112579
Open Access

Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Major Depressive Disorder (MDD) Treatment
Qian He, Adam N. Bennett, Kei Hang Katie Chan
(2025), pp. 1-22
Closed Access

Knowledge, attitude and practice towards self-medication among pharmacy students in tertiary care hospital
Sindhu Selvam, Shankar Srinivasan, Deena Krishnamoorthy, et al.
International Journal of Basic & Clinical Pharmacology (2025) Vol. 14, Iss. 2, pp. 224-232
Open Access

Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank
Michelle Kamp, Chris Wai Hang Lo, Grigorios Kokkinidis, et al.
Psychological Medicine (2025) Vol. 55
Open Access

The Insulin-like Growth Factor Family as a Potential Peripheral Biomarker in Psychiatric Disorders: A Systematic Review
Carlos Fernández-Pereira, Roberto Carlos Agís‐Balboa
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2561-2561
Open Access

Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis
Paula Jhoana Escobedo-Aedo, Chris Serrand, Sarah Kabani, et al.
Journal of Eating Disorders (2025) Vol. 13, Iss. 1
Open Access

The Impact of Mental Health on Total Joint Arthroplasty Outcomes
Maximillian Ganz, Matthew Whittaker, Giles R. Scuderi
Orthopedic Clinics of North America (2025)
Closed Access

Ethical considerations in LGBTQI+ clinical care
Thomas G. Plante
Ethics & Behavior (2025), pp. 1-8
Closed Access

Ventral targeted anterior capsulotomy for treatment-resistant depression and obsessive-compulsive disorder: A treatment method with cases
Trevor A. Hurwitz, Josué M. Avecillas-Chasín, Nicholas M. Bogod, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 887-894
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top